DJ Gilead Sciences Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) shed 1.20% to $124.33 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 3.40% short of its 52-week high of $128.70, which the company achieved on November 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $205.34, Pfizer Inc. $(PFE)$ fell 1.83% to $25.27, and Abbott Laboratories $(ABT)$ fell 0.69% to $128.01.
Trading volume (4.9 M) remained 2.6 million below its 50-day average volume of 7.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 01, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments